DELVINO PAOLO

Silvagni, E., Bortoluzzi, A., Occhino, G., Bellelli, G., Garaffoni, C., Delvino, P., et al. (2025). Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles. FRONTIERS IN PHARMACOLOGY, 16 [10.3389/fphar.2025.1565909]. Dettaglio

Delvino, P., Quartuccio, L., Robson, J., Ferretti, V., Klersy, C., Alberici, F., et al. (2025). Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study. RHEUMATOLOGY [10.1093/rheumatology/keaf232]. Dettaglio

Delvino, P., Baldini, C., Bonacini, M., Croci, S., Di Cianni, F., Ferro, F., et al. (2025). Systemic vasculitis: one year in review 2025. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 43(4), 553-562 [10.55563/clinexprheumatol/oyqz1p]. Dettaglio

Bartoletti, A., Milanesi, A., Monti, S., Montecucco, C., Delvino, P. (2025). Long-term maintenance of remission with spacing of rituximab infusions based on the individualised patient risk profile in ANCA-associated vasculitis: a pilot study. RMD OPEN, 11(2) [10.1136/rmdopen-2025-005504]. Dettaglio

Delvino, P., Strada, L., Carducci, M., Ripamonti, G., Dal Cin, S. (2025). Clinical Image: Extensive subcutaneous calcinosis cutis with fistulization in refractory dermatomyositis. ACR OPEN RHEUMATOLOGY, 7(1) [10.1002/acr2.11798]. Dettaglio